Spectroscopy Since 1975
Metrohm Advertisement

New IRXross FT-IR spectrophotometer

11 April 2022 | Product
by Ian Michael

This mid-level FT-IR spectrophotometer achieves upper-end performance including high-level S/N ratio, resolution, measurement speed and ease of use.

Shimadzu has introduced the IRXross™ Fourier transform infrared (FT-IR) spectrophotometer. Its P-P values of 55,000 : 1 for one minute of integration enable ultra-high-sensitivity measurements. Users also achieve high-resolution 0.25 cm–1 measurements. In addition, peaks from adjacent gas components are more easily separated using the IRXross compared to its predecessor. High-speed measurement of 20 spectra per second enables faster reaction tracking. It also acquires data with a best-in-class low noise level.

The IRXross FT-IR spectrophotometer includes built-in analytical intelligence, IR Pilot™, for easy start-up and navigation. The standard package includes 23 macro application programs. Even operators unfamiliar with FT-IR spectrophotometry can analyse samples easily by simply selecting the purpose of analysis and attachment they are using. Operators can analyse multiple samples with a single click and do not need to set parameters. Using IR Pilot, users can program the IRXross to specifically support identification testing by making pass/fail judgements for test samples based on verification methods specified in pharmacopoeia and official methods. They can also program the system to support contaminant analysis using Shimadzu’s proprietary algorithm in combination with a spectral library containing over 550 spectra for substances commonly detected as contaminants.

A wide variety of libraries, including Shimadzu’s unique libraries of reagents, polymers and more, is included as standard. Shimadzu also offers LabSolutions™ Software DB IR and LabSolutions CS IR to meet the requirements of Electronic Record and Electronic Signature regulations. In addition, the software includes built-in validation test macros for compliance with requirements from various pharmacopeia, including USP.